Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Ion Beam ApplicationsIOBCF +2.30%81 Equity-to-Asset is 0.18 as of Dec. 2025, which is 25% below its 10-year median of 0.24. GuruFocus rates IOBCF with a GF Score™ of 81/100 and a GF Value™ of $18.56 (Fairly Valued). The stock has 10 warning signs investors should review. Among 855 Medical Devices & Instruments companies, Ion Beam Applications ranks worse than 89.01% on this metric.
The historical rank and industry rank for Ion Beam Applications's Equity-to-Asset or its related term are showing as below:
IOBCF'
s Equity-to-Asset Range Over the Past 10 Years
Min: 0.18 Med: 0.24 Max: 0.4
Current: 0.18
During the past 13 years, the highest Equity to Asset Ratio of Ion Beam Applications was 0.40. The lowest was 0.18. And the median was 0.24.
IOBCF's Equity-to-Asset is ranked worse than 89.01% of 855
companies
in the Medical Devices & Instruments industry
Industry Median: 0.65
vs IOBCF: 0.18
Ion Beam Applications (OTCPK:IOBCF) Equity-to-Asset Explanation
Equity to Asset ratio can vary greatly across different industries, as they have different capital structure. A company with smaller Equity to Asset ratio (more leveraged) may have higher ROE % because of the leverage.
For banks, the required minimum Equity to Asset ratio by regulation is 5%. Some stronger banks may have Equity to Asset Ratio of more than 10%.
Ion Beam Applications Equity-to-Asset Related Terms
Ion Beam Applications Equity-to-Asset Historical Data
* Premium members only.
The historical data trend for Ion Beam Applications's Equity-to-Asset can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
IOBCF vs ABT, SYK, MDT: Equity-to-Asset Comparison
For the Medical Devices subindustry, Ion Beam Applications's Equity-to-Asset, along with its competitors' market caps and Equity-to-Asset data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Ion Beam Applications Equity-to-Asset vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Ion Beam Applications's Equity-to-Asset distribution charts can be found below:
* The bar in red indicates where Ion Beam Applications's Equity-to-Asset falls into.
Equity to Asset ratio measures the ratios of the portion of the asset owned by shareholders out of the total asset. It indicates the leverage of the company, and the amount of debt the company uses in its operation.
Equity to Asset ratio is calculated by dividing total stockholders equity by total asset.
Ion Beam Applications's Equity to Asset Ratio for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Ion Beam Applications (IOBCF) has a Equity-to-Asset of 0.18 as of Dec. 2025. Equity-to-asset ratio equals total company equity divided by total assets. It measures financial leverage. View historical data on Ion Beam Applications and its competitors. This is 25% below median its historical median of 0.24. Over the past decade, Ion Beam Applications' Equity-to-Asset has ranged from 0.18 to 0.40. According to the industry distribution chart, Ion Beam Applications ranks #761 out of 855 companies in the Medical Devices & Instruments industry, placing it in the top 89%.
Is Ion Beam Applications' Equity-to-Asset too high?
Ion Beam Applications' current Equity-to-Asset of 0.18 is 25% below median its 10-year median of 0.24. Over the past 10 years, this metric has ranged from a low of 0.18 to a high of 0.40. The Medical Devices & Instruments industry median Equity-to-Asset is 0.65. Ion Beam Applications' value of 0.18 is 72.3% below this industry median. Based on the distribution chart, Ion Beam Applications ranks #761 out of 855 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, Ion Beam Applications has a GF Score™ of 81/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Ion Beam Applications' Equity-to-Asset compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Ion Beam Applications ranks #761 out of 855 companies for Equity-to-Asset. This places Ion Beam Applications in the lower half of its industry. The industry median Equity-to-Asset is 0.65. Ion Beam Applications' value of 0.18 is 72.3% below this benchmark. Historically, Ion Beam Applications' own Equity-to-Asset has ranged from 0.18 to 0.40 over the past decade. While the company's 10-year median is 0.24 vs. the industry median of 0.65, Ion Beam Applications has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Equity-to-Asset for a Medical Devices & Instruments company?
The median Equity-to-Asset among Medical Devices & Instruments companies is 0.65, based on 855 companies in the industry. Companies in the top quartile (top 25%) have a Equity-to-Asset significantly above this median, while those in the bottom quartile fall well below. However, Equity-to-Asset should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Ion Beam Applications's current Equity-to-Asset of 0.18 is 72.3% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Equity-to-Asset mean?
A high Equity-to-Asset can signal that a stock is expensive relative to its fundamentals. Equity-to-asset ratio equals total company equity divided by total assets. It measures financial leverage. View historical data on Ion Beam Applications and its competitors. For the Medical Devices & Instruments industry, the median Equity-to-Asset is 0.65 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Ion Beam Applications's current Equity-to-Asset is 0.18, which is 25% below median its own 10-year median of 0.24. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Ion Beam Applications stock overvalued right now?
Based on GuruFocus' analysis, Ion Beam Applications (IOBCF) is currently considered Fairly Valued. The stock's GF Value™ is $18.56, compared to a current price of $19.62 — trading 5.7% above its estimated fair value. The current Equity-to-Asset is 0.18, which is 25% below median its 10-year median of 0.24 and 72.3% below the Medical Devices & Instruments industry median of 0.65. Ion Beam Applications' overall GF Score™ is 81/100 with 10 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Equity-to-Asset calculated?
Equity-to-Asset is calculated from a company's financial statements. For Ion Beam Applications (IOBCF), the current Equity-to-Asset is 0.18 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Ion Beam Applications (IOBCF) Overvalued in 2026?
Based on GuruFocus' analysis, Ion Beam Applications stock appears to be overvalued.
The current stock price of $19.62 is trading 5.7% above its estimated GF Value™ of $18.56.
GuruFocus considers Ion Beam Applications to be Fairly Valued.
Key valuation signals for IOBCF:
Equity-to-Asset: 0.18 (25% below median its 10-year median of 0.24)
GF Value™: $18.56 vs. price of $19.62 (5.7% above fair value)
Industry Position: 72.3% below the Medical Devices & Instruments median (#761 of 855)
No single metric tells the full story. See the IOBCF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Ion Beam Applications SA develops and manufactures medical devices and software solutions. The firm operates in three segments: IBA Clinical, including Proton Therapy and Dosimetry; IBA Technologies; and IBA Corporate. Proton therapy and other accelerators contribute to the majority of sales. It offers solutions for precision cancer treatment through the use of proton beams, as well as cyclotrons used for the production of radioisotopes and industrial accelerators for sterilization and ionization. The dosimetry business sells measurement and quality assurance instruments for radiotherapy and medical imaging. The firm operates in three geographical areas: Belgium, the United States, China, Germany, and India.
81GF Score
Get the complete analysis for IOBCF
Equity-to-Asset is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
IOBCF has been successfully added to your 
